Related Experiment Video
Updated: Apr 19, 2026
A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
Study of microRNA in diabetic nephropathy: isolation, quantification and biological function
Phillip Kantharidis1, Shinji Hagiwara, Eoin Brennan
1JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Diabetes Division, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Abstract:
In recent years, several studies have reported dysregulation of microRNA expression in disease with a growing interest focussed on targeting microRNAs as a novel therapy for human disease. This is especially true in diabetic nephropathy where the expression of several microRNAs is dysregulated, contributing to the increased expression and accumulation of extracellular matrix proteins and increased pro-fibrotic signalling, ultimately resulting in renal fibrosis. The development of various techniques and microRNA reagents has enabled work to progress very rapidly in this area. In the present article, the authors describe the methods they have used that have enabled them to contribute to our current understanding of the role of microRNAs in diabetic nephropathy.
Insights
MicroRNAs are key players in diabetic nephropathy, driving kidney fibrosis. Understanding their dysregulation offers new therapeutic targets for this complex disease.
Area of Science:
- Biomedical research
- Molecular biology
- Nephrology
Background:
- MicroRNA (miRNA) expression is frequently dysregulated in various human diseases.
- Diabetic nephropathy (DN) is characterized by altered miRNA profiles.
- These miRNA alterations contribute to extracellular matrix accumulation and renal fibrosis in DN.
Purpose of the Study:
- To investigate the role of microRNAs in the pathogenesis of diabetic nephropathy.
- To elucidate the mechanisms by which miRNAs contribute to renal fibrosis.
- To highlight novel therapeutic strategies targeting miRNAs in DN.
Main Methods:
- Review of current literature on miRNA research in diabetic nephropathy.
- Analysis of experimental techniques and reagents used in miRNA studies.
- Description of methods employed by the authors to advance understanding of miRNA function in DN.
Main Results:
- Dysregulated miRNA expression is a significant factor in DN progression.
- Specific miRNAs promote extracellular matrix deposition and pro-fibrotic signaling.
- Rapid advancements in miRNA research are providing new insights.
Conclusions:
- MicroRNAs are critical mediators of renal fibrosis in diabetic nephropathy.
- Targeting specific miRNAs presents a promising therapeutic avenue for DN.
- Continued research into miRNA mechanisms is essential for developing effective treatments.
More Related Videos
Related Concept Videos
01:28Diabetic Nephropathy
01:22MicroRNAs
01:22MicroRNAs
01:22MicroRNAs